The results of open observational trial DIAMOND
Aim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2011-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/6232 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850254304164708352 |
|---|---|
| author | Marina Vladimirovna Shestakova Olga Konstantinovna Vikulova |
| author_facet | Marina Vladimirovna Shestakova Olga Konstantinovna Vikulova |
| author_sort | Marina Vladimirovna Shestakova |
| collection | DOAJ |
| description | Aim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated with diet or one of oral antidiabeticdrug (OAD), were switched to Diamicron MB. Previous therapy was left unchanged, except for a sulfonylurea or glinide that were canceled. Results. After 6 months of Diamicron MB therapy (30% monotherapy, 70% combined therapy) target HbA1c |
| format | Article |
| id | doaj-art-e7749dfe1c75471fb9d3a9e4c0656bbc |
| institution | OA Journals |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2011-09-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-e7749dfe1c75471fb9d3a9e4c0656bbc2025-08-20T01:57:09ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782011-09-011439610210.14341/2072-0351-62326190The results of open observational trial DIAMONDMarina Vladimirovna Shestakova0Olga Konstantinovna Vikulova1Endocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowAim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated with diet or one of oral antidiabeticdrug (OAD), were switched to Diamicron MB. Previous therapy was left unchanged, except for a sulfonylurea or glinide that were canceled. Results. After 6 months of Diamicron MB therapy (30% monotherapy, 70% combined therapy) target HbA1chttps://www.dia-endojournals.ru/jour/article/view/6232type 2 diabetes mellitushypoglycemiadiamicron mbadvance trial |
| spellingShingle | Marina Vladimirovna Shestakova Olga Konstantinovna Vikulova The results of open observational trial DIAMOND Сахарный диабет type 2 diabetes mellitus hypoglycemia diamicron mb advance trial |
| title | The results of open observational trial DIAMOND |
| title_full | The results of open observational trial DIAMOND |
| title_fullStr | The results of open observational trial DIAMOND |
| title_full_unstemmed | The results of open observational trial DIAMOND |
| title_short | The results of open observational trial DIAMOND |
| title_sort | results of open observational trial diamond |
| topic | type 2 diabetes mellitus hypoglycemia diamicron mb advance trial |
| url | https://www.dia-endojournals.ru/jour/article/view/6232 |
| work_keys_str_mv | AT marinavladimirovnashestakova theresultsofopenobservationaltrialdiamond AT olgakonstantinovnavikulova theresultsofopenobservationaltrialdiamond AT marinavladimirovnashestakova resultsofopenobservationaltrialdiamond AT olgakonstantinovnavikulova resultsofopenobservationaltrialdiamond |